BioLineRx, Ltd. BLRX was a big mover last session with its shares rising over 11% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past month’s volatile price range of $1.24 to $1.45.
This clinical stage biopharmaceutical development company has seen one positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s climb can turn into more strength down the road.
BioLineRx currently has a Zacks Rank #2 (Buy) and its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs space may also consider Corcept Therapeutics Inc. CORT, which sports a Zacks Rank #1 (Strong Buy).
Is BLRX going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment